Clinical Trial Update: Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update noting the completion of a study evaluating imiquimod for preventing cervical cancer in women with cervical neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Aldara (imiquimod)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Cervical Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED